| Authors: |
Millan AJ; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, United States., Allain V; Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, United States.; INSERM UMR976, Hôpital Saint-Louis, Université Paris Cité, Paris, France., Nayak I; Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, College of Medicine, The Ohio State University, Columbus, OH, United States., Libang JB; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, United States., Quijada-Madrid LM; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, United States., Arakawa-Hoyt JS; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, United States., Ureno G; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, United States., Rothrock AG; Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.; Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, United States., Shemesh A; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, United States.; Department of Medicine, University of California, San Francisco, San Francisco, CA, United States., Aguilar OA; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, United States., Eyquem J; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, United States.; INSERM UMR976, Hôpital Saint-Louis, Université Paris Cité, Paris, France., Das J; Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, College of Medicine, The Ohio State University, Columbus, OH, United States.; Department of Pediatrics, Nationwide Children's Hospital, College of Medicine, The Ohio State University, Columbus, OH, United States.; Biomedical Sciences Graduate Program, College of Medicine, The Ohio State University, Columbus, OH, United States.; Pelotonia Institute for Immuno-Oncology, College of Medicine, The Ohio State University, Columbus, OH, United States., Lanier LL; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, United States.; Parker Institute for Cancer Immunotherapy, University of California, San Francisco, San Francisco, CA, United States. |
